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Summary  Histoid  Hansen’s  disease  is  a  rare  form  of  multibacillary  leprosy  with
distinct  clinical  and  histopathological  features.  This  type  of  leprosy  is  a  variant  of
lepromatous  leprosy  with  a  very  high  bacterial  reserve.  Of  alarming  concern  is  the
discovery  of  an  isolated  mucosal  histoid  leprotic  lesion  inside  the  nasal  cavity  of  a
patient  in  the  post-global  leprosy  elimination  era.  Our  case  had  no  history  of  leprosy
or  exposure  to  dapsone/multidrug  therapy  but  had  a  heavy  bacillary  index.  We  are
reporting  this  case  to  highlight  the  rarity  of  mucosal  lesions  due  to  histoid  leprosy
and  involvement  of  the  nasal  cavity,  as  well  as  to  create  awareness  and  avoid  mis-
diagnosis.  This  will  help  facilitate  prompt  treatment  to  minimize  the  complications
and  deformities  of  the  patient  and  prevent  its  spread  throughout  the  community.
©  2015  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Limited.  All  rights  reserved.∗ Corresponding author. Tel.: +91 9556524887.
E-mail address: santoshvoltaire@yahoo.co.in (S.K. Swain).
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eprosy  is a  chronic  infections  granulomatous  dis-
ase caused  by  Mycobacterium  leprae  with  high
nces. Published by Elsevier Limited. All rights reserved.
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[ucosal  histoid  Hansen’s  disease  
orbidity.  Histoid  leprosy  is  a  rare  variant  of  lep-
omatous  leprosy  with  incidence  varying  from  1%
o 2%  among  total  leprosy  patients  and  an  average
ge at  diagnosis  is  between  21  and  40  years  old  [1].
he adult  population  is  most  commonly  affected
ith a  male  predominance  [2]. The  bacillary  load
s high  in  these  patients  and  usually  presents  in
he lepromatous  types  as  well  as  in  patients  under-
oing  dapsone  monotherapy  and  dapsone-resistant
ases. Clinically,  histoid  leprosy  presents  as  asymp-
omatic,  with  discrete,  ﬁrm  shiny  papules  and
odules on  relatively  normal  appearing  skin.  The
ites of  predilection  are  the  extensor  surface  of  the
xtremities  and  lower  trunk  [1,3]. It  is  extremely
are in  the  genitalia,  which  occurs  in  more  severe
orm [3].  However,  the  etiopathogenesis  is  unclear.
he characteristic  histopathological  ﬁndings  in  con-
unction with  a  high  bacillary  index  conﬁrm  the
iagnosis  in  the  clinically  doubtful  cases.  As  the
acillary  load  is  very  high  in  these  patients,  they
an form  a  potential  reservoir  of  infection  in  the
ommunity.  The  mucosal  type  of  histoid  leprosy  is
xtremely  rare  in  the  community.  Here,  we  report
 case  of  isolated  mucosal  histoid  leprosy  in  a 45-
ear-old  man  from  the  post-elimination  area  of
disha, India,  where  the  prevalence  rate  of  the
isease  was  reported  to  be  1.47/10  000  people  in
arch 2014  (NLEP)  [4].
ase report
 45-year-old  male  presented  to  the  Outpatient
epartment  (OPD)  of  Ear,  Nose  and  Throat  (ENT)
ith a  right  nostril  block  that  existed  for  6  months
nd intermittent  nasal  bleeding  from  same  side
Fig.  1).  The  patient  had  neither  rhinorrhea  nor
nosmia  and  had  no  history  of  serious  illness.  Upon
nspection  and  an  anterior  rhinoscopy  procedure,
here was  a  small  reddish  mass  observed  in  the
nterior part  of  nasal  cavity.  A  diagnostic  nasal
ndoscopy  was  performed  to  conﬁrm  the  lesion
nside the  nasal  cavity  and  its  site  of  attachment.  A
omputed tomography  (CT)  scan  of  the  nose  and
aranasal  sinus  was  performed  to  determine  the
xact size  and  extent  of  the  mass  and  showed  that
he mass  was  conﬁned  to  the  anterior  region  of
he nasal  cavity,  primarily  the  anterior  region  of
he inferior  turbinate  attached  to  septum.  There
as no  history  of  sneezing  or  hyposmia,  and  the
ar and  throat  examinations  were  normal.  The  gen-
ral physical  examination,  systemic  examinations
nd routine  blood  tests  were  within  normal  lim-
ts. Infectious  diseases  such  as  HIV,  syphilis  and
uberculosis  were  ruled  out  by  ELISA,  VDRL  test
h
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iigure  1  Patient  presenting  with  a  mass  on  the  anterior
egion  of  the  right  nasal  cavity.
nd  Mantoux  test,  respectively.  The  split  skin  smear
xamination  for  Lepra  bacilli  was  performed  on
he bilateral  earlobes,  forehead,  cheeks  and  chin
nd was  negative  at  all  of  these  sites.  The  mass
as excised  endoscopically  under  general  anesthe-
ia after  taking  the  patient’s  consent,  and  the  mass
as sent  for  histopathological  examination.
The  biopsy  was  reported  as  the  histoid  type
f lepromatous  leprosy  (Fig.  2a and  b).  After  this
nexpected  histopathology  result,  a  more  in-depth
istory  was  collected.  The  patient  did  not  have
ny familial  background  of  the  disease  and  did  not
ention  any  contact  with  any  persons  suffering
rom leprosy.  There  were  no  cutaneous  or  periph-
ral nerve  involvements,  and  neither  hypoesthetic
atches nor  inﬁltration  were  discovered  on  the
kin. The  patient  was  referred  to  the  outpatient
epartment of  dermatology  for  further  evaluation
nd treatment  of  his  histoid  lepromatous  leprosy.
fter conﬁrmation  of  the  diagnosis,  the  patient  was
tarted on  anti-leprotic  multibacillary  therapy  with
ifampicin,  clofazimine  and  dapsone.  The  patient
as advised  for  regular  follow  up  and  has  responded
ell to  the  previous  6  months  of  treatment.
iscussion
istoid  leprosy  was  ﬁrst  reported  in  1963  by  Wade
5]. It  is  an  unusual  multibacillary  form  of leprosy
aving unique  clinical,  histological  and  bacterio-
ogical ﬁndings.  Irregular  and  inadequate  therapies
ith resistance  to  dapsone  and/or  mutated  organ-
sms (histoid  bacillus)  are  the  primary  factors  that
632  S.K.  Swain  et  al.
Figure  2  Microphotograph  showing  (a)  round  to  spindle-shaped  histiocytes  arranged  in  interlacing  bundles,  whorls
or  crisscross  patterns  (H&E,  400×), and  (b)  the  globi  of  lepra  bacilli  in  the  cytoplasm  of  histiocytes  (Wade-Fite  stain,
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cause  histoid  Hansen’s  disease  [6].  However,  the
patient  reported  here  has  no  past  history  of  leprosy
or drug  therapy  for  it.  This  form  of  Hansen’s  disease
has public  health  implications  in  this  post  elimi-
nation  era  as  it  belongs  to  the  lepromatous  pole
with high  infectivity  and  increased  risk  of  bacillary
transmission in  the  community.  Histoid  leprosy  is
considered  to  be  a  variant  of  lepromatous  leprosy,
and there  exists  an  enhanced  immune  response
against Mycobacterium  leprae  compared  to  lepro-
matous  leprosy  with  respect  to  both  cell-mediated
and humoral  immunity.  Although  there  are  an  ade-
quate number  of  macrophages,  one  study  claimed
that the  macrophages  are  unable  to  kill  the  bacilli
that exist  in  high  numbers  in  the  histoid  lesion  [6].
Histoid leprosy  in  nasal  cavity  may  present
with nasal  obstruction,  epistaxis,  rhinorrhea  and
hyposmia.  Evidence  of  nasal  mucosa  involvement
is observed  by  anterior  and  posterior  rhinoscopy.
Diagnostic nasal  endoscopy  and  radiological  tests
such as  a  CT  scan  of  the  nose  and  paranasal  sinuses
are useful  tools  to  assess  the  lesion  inside  the  nasal
cavity.
Histopathological  ﬁndings  of  the  histoid  nodules
showed fusiform  histiocytes  arranged  in  whorled,
criss-cross or  storiform  patterns.  Within  the  histio-
cytes, acid-resistant  bacilli  were  observed  in  large
numbers.  These  bacilli  are  longer  than  the  nor-
mal bacilli,  uniform  in  length,  more  solid  and  are
arranged  in  parallel  bundles  along  the  long  axis
of the  histiocytes.  There  was  epidermal  atrophy
and a  traditional  Grenz  zone  just  below  the  epi-
dermis  [7,8].  There  are  three  histological  variants
of histoid  leprosy:  pure  fusocellular,  fusocellular
o
t
a
pith  epithelioid  component  and  fusocellular  with
acuolated  cells,  the  latter  of  which  is most  com-
only observed  [9]. The  mucosal  histoid  Hansen
esion  clinically  simulates  different  granulomatous
esions of  the  nasal  cavity  such  as  syphilis,  tuber-
ulosis, rhinosporidiosis  and  rhinoscleroma,  as  well
s inverted  papilloma  and  malignancy  in  elderly
atients. Management  of  this  condition  includes
reating the  patient  with  a multidrug  anti-leprosy
egimen consisting  of  dapsone,  clofazimine  and
ifampicin.  Regular  follow-up  is  advised  for  these
atients  to  complete  the  treatment  and  prevent  the
pread of  infection,  as  India  was  declared  to  have
liminated  leprosy  [10]. The  mucosal  histoid  sub-
ype serves  as  a  reservoir  of  leprosy  and  as  a  source
f new  cases,  which  can  create  a serious  threat  to
ur elimination  program.
onclusion
he  high  bacillary  load  in  the  histoid  variety  of  lep-
osy is  a potential  reservoir  of  the  infection.  This
are mucosal  lesion  in  the  nasal  cavity  could  lead
o increased  likelihood  of  spreading  the  infection
o others.  It  is  essential  to  watch  for  new  cases  and
rovide complete  treatment  to  achieve  our  goal  of
he elimination  of  leprosy.  This  case  is  unique  in  the
ense that  this  mucosal  variety  of  histoid  leprosy
s extremely  rare,  and  this  patient  has  no  history
f either  leprosy  or  ingestion  of  dapsone/multidrug
herapy.  Histoid  leprosy  requires  early  detection
nd prompt  treatment,  which  should  be  made  a
riority in  the  national  program  against  leprosy.
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